US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.605
- -0.015-2.44%
Close May 23 16:00 ET
- 0.600
- -0.005-0.81%
Post 16:13 ET
48.36MMarket Cap-672P/E (TTM)
0.650High0.600Low548.92KVolume0.630Open0.620Pre Close333.11KTurnover0.75%Turnover RatioLossP/E (Static)79.94MShares2.53052wk High3.67P/B44.05MFloat Cap0.55352wk Low--Dividend TTM72.83MShs Float103.050Historical High--Div YieldTTM8.07%Amplitude0.545Historical Low0.606Avg Price1Lot Size
BioLine Rx Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.8M | 4.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --4.8M | --4.8M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 3.69M | 0 | ||||||||
| Gross profit | 1.11M | 0 | ||||||||
| Operating expense | 51.25%44.1M | 54.47%12.97M | 74.58%12.36M | 30.43%9.92M | 45.68%8.86M | 17.68%29.16M | 27.28%8.4M | 13.85%7.08M | 16.72%7.6M | 11.56%6.08M |
| Selling and administrative expenses | 171.83%31.23M | 93.12%9.52M | 255.48%9.63M | 213.05%6.91M | 214.60%5.17M | 118.05%11.49M | 244.69%4.93M | 109.35%2.71M | 60.63%2.21M | 40.39%1.64M |
| -Selling and marketing expense | 198.91%14.59M | -270.40%-3.02M | 517.39%8.13M | 383.94%5.6M | 508.16%3.87M | 547.48%4.88M | 7,595.65%1.77M | 433.20%1.32M | 250.91%1.16M | 313.64%637K |
| -General and administrative expense | 151.81%16.64M | 296.80%12.54M | 7.69%1.5M | 24.40%1.31M | 28.90%1.3M | 46.33%6.61M | 124.52%3.16M | 32.95%1.39M | 0.48%1.05M | -0.98%1.01M |
| Research and development costs | -28.99%12.52M | -9.56%3.1M | -37.58%2.73M | -44.28%3.01M | -16.93%3.68M | -9.44%17.63M | -33.09%3.43M | -11.25%4.37M | 4.98%5.4M | 3.67%4.44M |
| Depreciation amortization depletion | 800.00%351K | ---- | ---- | ---- | ---- | -7.14%39K | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | 800.00%351K | ---- | ---- | ---- | ---- | -7.14%39K | ---- | ---- | ---- | ---- |
| Operating profit | -47.45%-42.99M | -41.27%-11.86M | -74.58%-12.36M | -30.43%-9.92M | -45.68%-8.86M | -17.68%-29.16M | -27.28%-8.4M | -13.85%-7.08M | -16.72%-7.6M | -11.56%-6.08M |
| Net non-operating interest income expense | 85.51%-162K | 404.43%1.65M | -232.28%-525K | -200.00%-897K | -227.73%-390K | -53.36%-1.12M | -139.82%-542K | 24.40%-158K | -166.96%-299K | 34.62%-119K |
| Non-operating interest income | 189.19%2.01M | 63.93%718K | 186.24%312K | 450.00%440K | 701.49%537K | 150.54%694K | 2,090.91%438K | 109.62%109K | -38.46%80K | -42.74%67K |
| Non-operating interest expense | 20.04%2.14M | -200.31%-957K | 213.48%837K | 252.77%1.34M | 398.39%927K | 81.50%1.79M | 424.18%954K | 2.30%267K | 56.61%379K | -37.79%186K |
| Total other finance cost | -3.85%25K | ---- | ---- | ---- | ---- | 18.18%26K | ---- | ---- | ---- | ---- |
| Other net income (expense) | -427.97%-17.46M | -214.40%-3.67M | -907.46%-3.14M | -1,788.43%-7.73M | -329.97%-2.92M | 443.93%5.32M | 27.34%3.21M | -45.21%389K | 311.06%458K | 127.80%1.27M |
| Gain on sale of security | -280.84%-10.99M | ---- | ---- | ---- | ---- | 467.53%6.08M | ---- | ---- | ---- | ---- |
| Special income (charges) | ---6.7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --6.7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 131.13%235K | 588.68%14.03M | -907.46%-3.14M | -1,788.43%-7.73M | -329.97%-2.92M | -812.26%-755K | -168.76%-2.87M | -45.21%389K | 311.06%458K | 127.80%1.27M |
| Income before tax | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M | -8.78%-7.44M | 51.63%-4.93M |
| Income tax | ||||||||||
| Net income | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M | -8.78%-7.44M | 51.63%-4.93M |
| Net income continuous Operations | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M | -8.78%-7.44M | 51.63%-4.93M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -142.93%-60.61M | -142.26%-13.88M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M | -8.78%-7.44M | 51.63%-4.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -142.93%-60.61M | -142.26%-13.88M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M | -8.78%-7.44M | 51.63%-4.93M |
| Basic earnings per share | -100.00%-0.9 | -0.15 | -100.00%-0.3 | -100.00%-0.3 | 0.00%-0.15 | 25.00%-0.45 | 0 | 0.00%-0.15 | 0.00%-0.15 | 50.00%-0.15 |
| Diluted earnings per share | -100.00%-0.9 | -0.15 | -100.00%-0.3 | -100.00%-0.3 | 0.00%-0.15 | 25.00%-0.45 | 0 | 0.00%-0.15 | 0.00%-0.15 | 50.00%-0.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg